Ophthalmology

29.05.2024 • News

MSD to Acquire EyeBio for up to $3 Billion

US drugmaker Merck & Co. (MSD) has agreed to acquire privately held ophthalmology-focused biotechnology company Eyebiotech (EyeBio).

08.03.2024 • News

Sandoz Acquires Ophthalmology Franchise from Coherus

In a move to expand its ophthalmic platform, Sandoz, the former generics and biosimilars arm of Swiss drugmaker Novartis, has completed the acquisition of Coherus BioSciences’ subsidiary Coherus Ophthalmology for $170 million.

13.12.2017 • News

Bayer Combines Pharma R&D in one Unit

19.05.2016 • News

Novartis Splits Pharmaceutical Division

Top-Feature

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

Ecocool GmbH

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

CHEManager International c/o Wiley-VCH GmbH

Digitalization in the Chemical Industry

Evonik Operations GmbH (Hanau)

Biobased Feedstocks as a Roadmap to Defossilization

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

Free Virtual Event

Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Merck & Co